Cargando…

Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City

BACKGROUND: Fatal heroin overdose is a significant cause of mortality for injection drug users (IDUs). Many of these deaths are preventable because opiate overdoses can be quickly and safely reversed through the injection of Naloxone [brand name Narcan], a prescription drug used to revive persons wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Piper, Tinka Markham, Rudenstine, Sasha, Stancliff, Sharon, Sherman, Susan, Nandi, Vijay, Clear, Allan, Galea, Sandro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797013/
https://www.ncbi.nlm.nih.gov/pubmed/17254345
http://dx.doi.org/10.1186/1477-7517-4-3
_version_ 1782132281639436288
author Piper, Tinka Markham
Rudenstine, Sasha
Stancliff, Sharon
Sherman, Susan
Nandi, Vijay
Clear, Allan
Galea, Sandro
author_facet Piper, Tinka Markham
Rudenstine, Sasha
Stancliff, Sharon
Sherman, Susan
Nandi, Vijay
Clear, Allan
Galea, Sandro
author_sort Piper, Tinka Markham
collection PubMed
description BACKGROUND: Fatal heroin overdose is a significant cause of mortality for injection drug users (IDUs). Many of these deaths are preventable because opiate overdoses can be quickly and safely reversed through the injection of Naloxone [brand name Narcan], a prescription drug used to revive persons who have overdosed on heroin or other opioids. Currently, in several cities in the United States, drug users are being trained in naloxone administration and given naloxone for immediate and successful reversals of opiate overdoses. There has been very little formal description of the challenges faced in the development and implementation of large-scale IDU naloxone administration training and distribution programs and the lessons learned during this process. METHODS: During a one year period, over 1,000 participants were trained in SKOOP (Skills and Knowledge on Opiate Prevention) and received a prescription for naloxone by a medical doctor on site at a syringe exchange program (SEP) in New York City. Participants in SKOOP were over the age of 18, current participants of SEPs, and current or former drug users. We present details about program design and lessons learned during the development and implementation of SKOOP. Lessons learned described in the manuscript are collectively articulated by the evaluators and implementers of the project. RESULTS: There were six primary challenges and lessons learned in developing, implementing, and evaluating SKOOP. These include a) political climate surrounding naloxone distribution; b) extant prescription drug laws; c) initial low levels of recruitment into the program; d) development of participant appropriate training methodology; e) challenges in the design of a suitable formal evaluation; and f) evolution of program response to naloxone. CONCLUSION: Other naloxone distribution programs may anticipate similar challenges to SKOOP and we identify mechanisms to address them. Strategies include being flexible in program planning and implementation, developing evaluation instruments for feasibility and simplicity, and responding to and incorporating feedback from participants.
format Text
id pubmed-1797013
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17970132007-02-13 Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City Piper, Tinka Markham Rudenstine, Sasha Stancliff, Sharon Sherman, Susan Nandi, Vijay Clear, Allan Galea, Sandro Harm Reduct J Research BACKGROUND: Fatal heroin overdose is a significant cause of mortality for injection drug users (IDUs). Many of these deaths are preventable because opiate overdoses can be quickly and safely reversed through the injection of Naloxone [brand name Narcan], a prescription drug used to revive persons who have overdosed on heroin or other opioids. Currently, in several cities in the United States, drug users are being trained in naloxone administration and given naloxone for immediate and successful reversals of opiate overdoses. There has been very little formal description of the challenges faced in the development and implementation of large-scale IDU naloxone administration training and distribution programs and the lessons learned during this process. METHODS: During a one year period, over 1,000 participants were trained in SKOOP (Skills and Knowledge on Opiate Prevention) and received a prescription for naloxone by a medical doctor on site at a syringe exchange program (SEP) in New York City. Participants in SKOOP were over the age of 18, current participants of SEPs, and current or former drug users. We present details about program design and lessons learned during the development and implementation of SKOOP. Lessons learned described in the manuscript are collectively articulated by the evaluators and implementers of the project. RESULTS: There were six primary challenges and lessons learned in developing, implementing, and evaluating SKOOP. These include a) political climate surrounding naloxone distribution; b) extant prescription drug laws; c) initial low levels of recruitment into the program; d) development of participant appropriate training methodology; e) challenges in the design of a suitable formal evaluation; and f) evolution of program response to naloxone. CONCLUSION: Other naloxone distribution programs may anticipate similar challenges to SKOOP and we identify mechanisms to address them. Strategies include being flexible in program planning and implementation, developing evaluation instruments for feasibility and simplicity, and responding to and incorporating feedback from participants. BioMed Central 2007-01-25 /pmc/articles/PMC1797013/ /pubmed/17254345 http://dx.doi.org/10.1186/1477-7517-4-3 Text en Copyright © 2007 Piper et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Piper, Tinka Markham
Rudenstine, Sasha
Stancliff, Sharon
Sherman, Susan
Nandi, Vijay
Clear, Allan
Galea, Sandro
Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City
title Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City
title_full Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City
title_fullStr Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City
title_full_unstemmed Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City
title_short Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City
title_sort overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in new york city
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797013/
https://www.ncbi.nlm.nih.gov/pubmed/17254345
http://dx.doi.org/10.1186/1477-7517-4-3
work_keys_str_mv AT pipertinkamarkham overdosepreventionforinjectiondruguserslessonslearnedfromnaloxonetraininganddistributionprogramsinnewyorkcity
AT rudenstinesasha overdosepreventionforinjectiondruguserslessonslearnedfromnaloxonetraininganddistributionprogramsinnewyorkcity
AT stancliffsharon overdosepreventionforinjectiondruguserslessonslearnedfromnaloxonetraininganddistributionprogramsinnewyorkcity
AT shermansusan overdosepreventionforinjectiondruguserslessonslearnedfromnaloxonetraininganddistributionprogramsinnewyorkcity
AT nandivijay overdosepreventionforinjectiondruguserslessonslearnedfromnaloxonetraininganddistributionprogramsinnewyorkcity
AT clearallan overdosepreventionforinjectiondruguserslessonslearnedfromnaloxonetraininganddistributionprogramsinnewyorkcity
AT galeasandro overdosepreventionforinjectiondruguserslessonslearnedfromnaloxonetraininganddistributionprogramsinnewyorkcity